Nuvation Bio Inc. (NUVB) financials

Nuvation Bio Inc. (NUVB) revenue, EBIT and EBITDA, earnings per share, free cash flow, margins, debt and shareholders equity — annual and quarterly history, charted from SEC filings. No account needed.

In fiscal 2025, Nuvation Bio Inc. reported revenue of $63M, up 699.0% year over year, net income of -$205M and diluted EPS of -$0.60.

Revenue (fiscal 2025)

$63M

Revenue growth (fiscal 2025)

699.0%

Net income (fiscal 2025)

-$205M

Diluted EPS (fiscal 2025)

-$0.60

Nuvation Bio Inc. files with the U.S. Securities and Exchange Commission under CIK 0001811063, classified as Pharmaceutical Preparations.

Explore annual and quarterly revenue, earnings, cash flow, margins, debt and equity from SEC filings.